期刊文献+

加减益肝化石汤阻止取石术后胆石复发作用的观察及对胆汁成石基因的影响 被引量:6

Yiganhuashi decoction changes B-UGT,CYP7A1 and prevents the recurrence of common duct stones
原文传递
导出
摘要 [目的]观察益肝化石汤预防胆总管结石患者经内镜逆行胰胆管造影(encoscopicretrograde cholangio-pancreatography,ERCP)+十二指肠乳头切开取石术后胆石复发的疗效,及其对胆汁成石基因血胆红素尿苷二磷酸葡萄糖醛酸基转移酶(B-UGT)与胆固醇7α羟化酶(CYP7A1)的影响。[方法]入选对象700例,均为ERCP乳头切开取石成功患者。研究分为两部分:①将600例随机分为A、B组,每组300例。A组口服中药益肝化石汤100ml,2次/d,每月服用不少于6~7剂,每年服药不少于70剂;B组未服任何药物。2组同时进行随访,随访时间6~60(平均48)个月,每半年或出现腹痛症状时经腹部B超、CT、磁共振胰胆管造影复查;以失访和治疗依从性差为截尾,采用Kaplan-Meier法进行复发概率分析2组结石复发率。②将100例随机分成C、D组各50例。C组在常规治疗基础上,加服益肝化石汤;D组仅给予常规治疗。检测并比较2组服药前、服药后第7天、1个月血B-UGT、CYP7A1mRNA的表达。[结果]①A组有19例复发,B组有33例复发,2组术后结石累计复发概率分别是6.3%和11.0%,2组比较,差异有统计学意义(P<0.05)。②成石基因检测显示,C组治疗后血中B-UGT、CYP7A1mRNA蛋白表达较治疗前明显升高(P<0.05),D组治疗前后两基因及蛋白表达无变化。[结论]益肝化石汤辨证施治可有效预防ERCP取石术后患者的胆石症复发,其机制可能是通过上调B-UGT、CYP7A1mRNA表达,抑制成石性胆汁的形成。 [Objective]To observe the prevention effect on the recurrence of common duct stones in pa- tients with post-ERCP/EST by Yiganhuashi decoction and the effect on B-UGT,CYP7A1. [Methods]①Six hundred patients diagnosed as choledocholith whose calculus were removed with mechanical lithotripsy and reticular baske were randomly divided into two groups, experimental group(n=300)given Yiganhuashi de- coction 100 ml, bid, for at least 6 days per month, the control group(n=300)given nothing. All patients were followed-up 6 to 60 months(average of 48 months), and abdominal B ultrasound, CT, MRCP were re- viewed every six months. ②The same one hundred patients were randomly divided into two groups, the control group(n= 50) and the Yiganhuashi decoction(n= 50). The patients of control group were treatedwith the normal anti-inflammatory therapy. The other group was treated with the Yiganhuashi decoc- tion. The expression of B-UGT, CYP7A1 in the blood was detected by RT-PCR and Western blot at the first, seventh and thirtieth day after the therapy. [Results]①Nineteen cases of recurrence were found in the experimental group, however, thirty-three cases in control group, and the probability of postoperative stone cumulative recurrence were 6.3% and 11 % respectively. Statistically significant difference was found be- tween two groups (X2 = 4. 361, P = 0.037). ②The high expression of B-UGT, CYP7A1 was found in experi- ment group(P(0. 05). However,there were no changes in the control group. [Conelusion]Yiganhuashi de- coction is effective in preventing recurrence after ERCP/EST stone extraction in patients with common duct stones by regulating the expression B-UGT,CYPTA1.
出处 《中国中西医结合消化杂志》 CAS 2013年第2期73-76,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
关键词 胆总管结石 益肝化石汤 预防 胆红素尿苷二磷酸葡萄糖醛酸基转移酶 胆固醇7 a羟化酶 common duct stones prevention Yiganhuashi decoction bilirubin UDP-glucurono- syltransferase cholesterol 7 alpha-hydroxylase
  • 相关文献

参考文献3

二级参考文献25

  • 1高丹枫.利胆排石汤治疗胆石症术后结石40例临床观察[J].中医杂志,2004,45(8):597-598. 被引量:12
  • 2王长洪,杨卓,麻树人,张宁,王立新,李顺明,杨琳,常丽娅,宫照洁,林一帆,陈山泉,陆宇平,高文艳,刘杨,朱虹.乳头小切开合利胆排石中药治疗胆总管结石疗效观察[J].中国中西医结合消化杂志,2006,14(1):20-22. 被引量:6
  • 3韩兵,王宝仁.ERCP术后急性胰腺炎并发症的危险因素及预防研究进展[J].世界华人消化杂志,2006,14(18):1813-1818. 被引量:27
  • 4宋曼萍.变频电针治疗胆石症的临床观察[J].中国针灸,2006,26(11):772-774. 被引量:16
  • 5TSUJINO T, KOMATSU YF, ISAYAMA H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial[J]. Clin Gastroenterol Hepatol, 2005, 3 (4) : 376 - 383.
  • 6Riity S, Sand J, Pulkkinen M, et al. Post-ERCP pancreatitis:reduetion by routine antibioties[J]. J Gastrointest Surg, 2001,5 (4) : 339-345.
  • 7Panteris V,Vezakis A,Filippou G,et al.Influence of juxtapapillary diverticula on the success or difficulty of cannulation and complication rate.Gastrointest Endosc,2008,68:903-910.
  • 8高田忠敬,二村雄次.胆道外科.1版.日本医学书院出版社,2005:42-45.
  • 9名石隆吉,清住雄昭,上田城久朗,他.胆管結石に対する内視鏡的乳頭括約筋切開術(EST)にぉける胆管結石の単回再発、累再発例の検討.胆と膵,2010,31:239-245.
  • 10宇野耕治,安田健治朗,森川宗一郎,他.内視鏡的乳頭括約筋切開下切石術(EST-L)の長期予後.胆と膵,2010,31:247-250.

共引文献30

同被引文献60

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部